Free Trial
NASDAQ:PRTC

PureTech Health (PRTC) Stock Price, News & Analysis

$29.25
0.00 (0.00%)
(As of 05/24/2024 ET)
Today's Range
$29.25
$29.25
50-Day Range
$25.48
$30.91
52-Week Range
$17.08
$34.00
Volume
4 shs
Average Volume
714 shs
Market Capitalization
$790.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PureTech Health MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.49mentions of PureTech Health in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($2.73) to ($5.17) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.08 out of 5 stars

Medical Sector

919th out of 923 stocks

Pharmaceutical Preparations Industry

428th out of 429 stocks

PRTC stock logo

About PureTech Health Stock (NASDAQ:PRTC)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

PRTC Stock Price History

PRTC Stock News Headlines

PureTech Health: Notice of Results
AKLI Mar 2024 3.000 call
PureTech to Present at Two Upcoming Investor Conferences
PureTech to Present at Two Upcoming Investor Conferences
PureTech Health plc (PRTC)
LSE:PRTC (PureTech Health plc)
PRTC PureTech Health plc
PureTech outlook for 2024
See More Headlines
Receive PRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/26/2024
Next Earnings (Estimated)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRTC
Employees
90
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.33 million
Book Value
$16.94 per share

Miscellaneous

Free Float
25,608,000
Market Cap
$790.92 million
Optionable
Not Optionable
Beta
1.21
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Bharatt M. Chowrira J.D. (Age 59)
    Ph.D., CEO & Executive Director
    Comp: $2.19M
  • Ms. Daphne Zohar (Age 53)
    Founder, Senior Advisor & Board Observer
    Comp: $3.99M
  • Dr. Robert S. Langer Jr. (Age 75)
    Ph.D., Co-Founder & Non-Executive Director
    Comp: $135k
  • Dr. Eric Elenko Ph.D. (Age 51)
    President
  • Dr. David R. Elmaleh Ph.D. (Age 76)
    Co-Founder & Senior Advisor
  • Mr. Eric Green M.B.A.
    Chief Operating Officer
  • Ms. Allison Mead Talbot
    Head of Communications & Investor Relations
  • Mr. Charles Sherwood III
    J.D., Ph.D., General Counsel & Company Secretary
  • Mr. Spencer Ball
    Senior Vice President of Human Resources
  • Ms. Aleksandra Filipovic M.D.
    Ph.D., Head of Oncology

PRTC Stock Analysis - Frequently Asked Questions

How have PRTC shares performed in 2024?

PureTech Health's stock was trading at $28.18 at the beginning of 2024. Since then, PRTC stock has increased by 3.8% and is now trading at $29.25.
View the best growth stocks for 2024 here
.

When is PureTech Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our PRTC earnings forecast
.

Who are PureTech Health's major shareholders?

PureTech Health's stock is owned by a number of retail and institutional investors. Top institutional investors include AWM Investment Company Inc. (0.03%).

How do I buy shares of PureTech Health?

Shares of PRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRTC) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners